181 related articles for article (PubMed ID: 37776519)
1. Cytotoxic CD4 development requires CD4 effectors to concurrently recognize local antigen and encounter type I IFN-induced IL-15.
Devarajan P; Vong AM; Castonguay CH; Silverstein NJ; Kugler-Umana O; Bautista BL; Kelly KA; Luban J; Swain SL
Cell Rep; 2023 Oct; 42(10):113182. PubMed ID: 37776519
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
Knudson CJ; Férez M; Alves-Peixoto P; Erkes DA; Melo-Silva CR; Tang L; Snyder CM; Sigal LJ
J Virol; 2021 Sep; 95(19):e0056621. PubMed ID: 34260270
[TBL] [Abstract][Full Text] [Related]
3. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.
Wang Y; Da'Dara AA; Thomas PG; Harn DA
Immunology; 2010 Mar; 129(3):406-17. PubMed ID: 19922421
[TBL] [Abstract][Full Text] [Related]
5. NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.
Marshall NB; Vong AM; Devarajan P; Brauner MD; Kuang Y; Nayar R; Schutten EA; Castonguay CH; Berg LJ; Nutt SL; Swain SL
J Immunol; 2017 Feb; 198(3):1142-1155. PubMed ID: 28031335
[TBL] [Abstract][Full Text] [Related]
6. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
7. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A
J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126
[TBL] [Abstract][Full Text] [Related]
8. Strong influenza-induced T
Devarajan P; Vong AM; Castonguay CH; Kugler-Umana O; Bautista BL; Jones MC; Kelly KA; Xia J; Swain SL
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177472
[TBL] [Abstract][Full Text] [Related]
9. The role of T-cell-mediated mechanisms in virus infections of the nervous system.
Dörries R
Curr Top Microbiol Immunol; 2001; 253():219-45. PubMed ID: 11417137
[TBL] [Abstract][Full Text] [Related]
10. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
11. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major.
Lemos MP; Esquivel F; Scott P; Laufer TM
J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255
[TBL] [Abstract][Full Text] [Related]
12. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
Croft M; Carter L; Swain SL; Dutton RW
J Exp Med; 1994 Nov; 180(5):1715-28. PubMed ID: 7525836
[TBL] [Abstract][Full Text] [Related]
13. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
Asnagli H; Schmitt-Verhulst AM; Guimezanes A
J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
[TBL] [Abstract][Full Text] [Related]
14. Clonal analysis of functionally distinct human CD4+ T cell subsets.
Rotteveel FT; Kokkelink I; van Lier RA; Kuenen B; Meager A; Miedema F; Lucas CJ
J Exp Med; 1988 Nov; 168(5):1659-73. PubMed ID: 2903211
[TBL] [Abstract][Full Text] [Related]
15. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
17. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.
Xiang J; Huang H; Liu Y
J Immunol; 2005 Jun; 174(12):7497-505. PubMed ID: 15944248
[TBL] [Abstract][Full Text] [Related]
18. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
20. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
